查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375934

泌尿系统肉毒桿菌毒素市场规模、份额和趋势分析报告：按应用、最终用途、地区和细分市场预测，2023-2030 年

Botulinum Toxin In Urology Market Size, Share & Trends Analysis Report By Application (Overactive Bladder, Neurogenic Detrusor Overactivity), By End-use (Hospitals, Urology Clinics), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

肉毒桿菌毒素市场成长与泌尿系统趋势：

Grand View Research 的最新报告显示，到 2030 年，全球泌尿系统肉毒桿菌市场预计将达到 14.5 亿美元。

预计 2023 年至 2030 年该市场将以 6.0% 的年复合成长率成长。由于神经源性膀胱的盛行率不断上升，以及与泌尿状况问题和尿失禁相关的老年人口不断增加，对肉毒桿菌毒素的需求不断增长。例如，根据 2020 年美国人口普查局的数据，2023 年 5 月，约有 5,580 万人，即美国人口的 16.8%，被归类为老年人。因此，老年人口的增加导致泌尿系统疾病问题的增加，进一步导致市场成长。

根据澳洲失禁基金会 2023 年 5 月的数据，澳洲约 38% 的女性和 10% 的男性患有尿失禁。因此，尿失禁盛行率的增加推动了市场的成长。尿失禁的原因包括便秘、骨盆底疾病、中风和某些药物的副作用。

然而，政府和私人组织增加对研发的投资，探索泌尿系统肉毒桿菌的治疗方法，正在为市场创造新的机会。例如，2022 年 7 月，艾伯维公司 (AbbVie Inc.) 和艾尔建 PLC (Allergan PLC) 在新奥尔良举行的 TOXINS 2022 大会上进行了 30 多场演讲，其中包括 7 场讲台演讲。其中重点介绍了 A 型肉毒桿菌毒素的临床前研究、临床研究和实际使用资料。因此，来自不同机构的资金增加正在推动市场成长。

泌尿系统市场报告亮点中的肉毒桿菌毒素

  • 从应用来看，膀胱过动症细分市场预计将在 2022 年占据最大的市场占有率，达到 67.14%，并在预测期内实现最快的年复合成长率。腹部创伤、过量饮酒和神经损伤等因素会增加膀胱过动症的发生率，进一步加剧该节段的生长。
  • 按最终用途划分，医院细分市场占据最大市场占有率，2022 年将达到 73.74%。新兴市场的医院数量不断增加和技术进步正在推动该领域的市场成长。
  • 北美地区成为市场领先地区，2022 年占最大份额，达 37.41%。该地区强大的医疗基础设施、熟练的医疗专业人员和先进的医疗设施促进了该地区的市场成长。
  • 由于慢性病和糖尿病盛行率不断上升，预计亚太地区在预测期内的复合年复合成长率将达到 7.3%。

目录

第1章调查方法和范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场体系展望
  • 市场趋势及展望
  • 市场动态
  • 市场抑制因素分析
  • 营商环境分析
  • 经济影响分析

第4章应用业务分析

  • 泌尿系统市场中的肉毒桿菌毒素，按应用分：要点
  • 泌尿系统市场肉毒桿菌：2022年和2030年应用趋势和市场占有率分析
  • 膀胱过动症
    • 2018-2030 年全球膀胱过动症市场估计与预测
  • 神经源性逼尿肌过度活动
    • 2018-2030 年全球神经源性逼尿肌过度活动市场估计与预测

第5章最终用途业务分析

  • 泌尿系统肉毒桿菌毒素市场（依最终用途）：重点
  • 泌尿系统肉毒桿菌毒素市场：2022 年和 2030 年最终用途趋势和市场占有率分析
  • 医院
  • 泌尿系统诊所

第6章区域业务分析

  • 区域市场简介
  • 北美洲
    • 北美泌尿系统肉毒桿菌毒素市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲泌尿系统肉毒桿菌毒素市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区泌尿系统肉毒桿菌市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲泌尿系统肉毒桿菌市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东及非洲泌尿系统肉毒桿菌市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 公司分类
  • 策略规划
  • 公司简介/名单
    • AbbVie Inc.
    • Merz Pharma
    • Ipsen Pharma
    • GALDERMA
    • Allergan PLC
    • Sun Pharmaceutical Industries Ltd.
    • Biovencer Healthcare Pvt Ltd
Product Code: GVR-4-68040-138-5

Botulinum Toxin In Urology Market Growth & Trends:

The global botulinum toxin in urology market size is anticipated to reach USD 1.45 billion by 2030, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 6.0% from 2023 to 2030. The demand for botulinum toxin is growing due to a rise in the prevalence of neurogenic bladder, rising geriatric population associated with urinary condition problems and urinary incontinence. For instance, in May 2023, according to the U.S. Census Bureau 2020, around 55.8 million or 16.8% of the population in the U.S. has been classified as older. As a result, the rising geriatric population has led to an increase in urinary condition problems, further leading to market growth.

In addition, in May 2023, according to the Continence Foundation of Australia, urinary incontinence affects about 38% of women and 10% of men in Australia. Thus, the increase in the prevalence of urinary incontinence raised the growth of the market. Urinary incontinence is caused due to constipation, pelvic floor disorders, stroke, and side effects of certain medications.

However, rising investment in R&D by government and private organizations to explore the therapeutic approach of botulinum in the urology sector creates new opportunities for the market. For instance, in July 2022, AbbVie Inc. and Allergan PLC presented more than 30 abstracts, including seven podium presentations at the TOXINS 2022 Conference in New Orleans. It highlighted preclinical research, clinical studies, and real-world utilization data of onabotulinumtoxinA. Thus, increased funding by various institutions boosts market growth.

Botulinum Toxin In Urology Market Report Highlights:

  • In terms of application, the overactive bladder segment held the largest market share of 67.14% in 2022 and it is anticipated to register the fastest CAGR over the forecast period. Factors such as abdominal trauma, excessive alcohol consumption, and nerve damage increase the incidence of overactive bladder, further increasing the segment's growth
  • Based on end-use, the hospitals segment held the largest market share of 73.74% in 2022. The growing number of hospitals in developing nations and technological advancements are fueling the market growth of this segment
  • North America region emerged as the leading market region in 2022, holding the largest share of 37.41%. The region's robust healthcare infrastructure, skilled healthcare professionals, and advanced medical facilities contribute to the market growth in the region.
  • The Asia Pacific region is anticipated to register the fastest CAGR of 7.3% over the forecast period owing to the increased prevalence of chronic diseases and diabetes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
      • 1.5.1.1. Approach 1: Commodity flow approach
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Restraint Analysis
  • 3.5. Business Environment Analysis
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.5.2. Porter's Five Forces Analysis
  • 3.6. Economic Impact Analysis

Chapter 4. Application Business Analysis

  • 4.1. Botulinum Toxin In Urology Market, By Application: Key Takeaways
  • 4.2. Botulinum Toxin In Urology Market: Application Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Overactive Bladder
    • 4.3.1. Global Overactive Bladder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Neurogenic Detrusor Overactivity
    • 4.4.1. Global Neurogenic Detrusor Overactivity Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Botulinum Toxin In Urology Market, By End-use: Key Takeaways
  • 5.2. Botulinum Toxin In Urology Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Urology Clinics
    • 5.4.1. Global Urology Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Germany Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. UK Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Profiles/Listing
    • 7.3.1. AbbVie Inc.
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Merz Pharma
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Ipsen Pharma
      • 7.3.3.1. Overview
      • 7.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. GALDERMA
      • 7.3.4.1. Overview
      • 7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Allergan PLC
      • 7.3.5.1. Overview
      • 7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Sun Pharmaceutical Industries Ltd.
      • 7.3.6.1. Overview
      • 7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Biovencer Healthcare Pvt Ltd
      • 7.3.7.1. Overview
      • 7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 3 Global Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global Botulinum Toxin In Urology Market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Botulinum Toxin In Urology Market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America Botulinum Toxin In Urology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. Botulinum Toxin In Urology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 Canada Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Botulinum Toxin In Urology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Botulinum Toxin In Urology Market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 16 Germany Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 18 UK Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 20 France Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 22 Italy Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 24 Spain Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 26 Denmark Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 28 Sweden Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 30 Norway Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Botulinum Toxin In Urology Market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 China Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 35 China Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Japan Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 37 Japan Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 India Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 39 India Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 41 South Korea Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Australia Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 43 Australia Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Thailand Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 45 Thailand Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America Botulinum Toxin In Urology Market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 48 Latin America Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 50 Brazil Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 52 Mexico Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 54 Argentina Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 South Africa Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Africa Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 UAE Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 62 UAE Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Kuwait Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Botulinum Toxin In Urology Market Segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market Trends & outlook
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's Five Forces analysis
  • Fig. 14 Global Botulinum Toxin In Urology Market: Application Outlook Key Takeaways
  • Fig. 15 Global Botulinum Toxin In Urology Market: Application Movement Analysis
  • Fig. 16 Global Overactive Bladder Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Neurogenic Detrusor Overactivity Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Botulinum Toxin In Urology Market: End-use Outlook Key Takeaways
  • Fig. 19 Global Botulinum Toxin In Urology Market: End-use Movement Analysis
  • Fig. 20 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Urology Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 22 Regional Marketplace: Key Takeaways
  • Fig. 23 Regional Outlook, 2022 & 2030
  • Fig. 24 Global Botulinum Toxin In Urology Market: Region Movement Analysis
  • Fig. 25 North America Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 28 Europe Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 29 Germany Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 30 UK Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 31 France Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 32 Italy Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 33 Spain Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 40 China Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 41 India Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)